|
|
 |
 |
|
Multiple Myeloma
You may have never heard of Multiple Myeloma, but it's a leukemia-related cancer that kills more than 20 thousand Americans every year. And the amazing truth is therapies that have a terrible public perception are having a positive impact on Multiple Myeloma. Therapies like arsenic and thalidomide are being investigated for their potential benefit in killing Myeloma cells, and giving patients a better quality, longer life. Tune into this episode of the Cutting Edge Medical Report to discover some of the other therapies that are helping Multiple Myeloma patients. You'll see new treatments that are helping clinicians expand the life-expectancy for this condition from 3-to-5 years, to six, seven years and beyond.
|
|
|
